Catalyst
Slingshot members are tracking this event:
Synergy Pharma (SGYP) Presents Data from First Phase 3 Trial Evaluating Plecanatide in Irritable Bowel Syndrome with Constipation (IBS-C)
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| SGYP |
|
|
||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Dec 09, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Plecanatide, Irritable Bowel Syndrome, Constipation, Ibs-c, Phase 3
